If you have ever read about ECT, you have probably seen the word "electrodes" and not much explanation of what that means in practice. It turns out the placement matters enormously.
This review looked at ECT for depression that has not responded to at least two different antidepressants. One of its clearest findings is that placing the electrodes on one side of the head only — called right unilateral placement — works about as well for major depression as placing them on both sides, but comes with fewer problems with thinking and memory afterwards.
That is a genuinely useful thing to know if ECT is being discussed for you or someone you love, because it is a question you can ask. Not every side effect is an unavoidable price of treatment; some depend on choices your treating team makes.
The review is honest about the limits of current knowledge too. Researchers have found changes in brain volume after ECT and some signals about who responds best, but exactly why ECT lifts depression is still not settled.
If depression has not shifted despite trying more than one medication, it is worth asking your GP or psychiatrist what options remain — there are usually more than people expect.
What this review actually looked at
This paper, by Subramanian et al., is a qualitative review. That means the authors did not treat any patients themselves. Instead they gathered and synthesised existing research on electroconvulsive therapy (ECT) for treatment resistant depression (TRD) — depression that has not improved after two adequate trials of different antidepressants, given at proper doses for a proper length of time. The review had three aims: to summarise how well ECT works for TRD, to look at how technical settings can be adjusted to improve results and limit side effects, and to describe what is currently understood about how ECT changes the brain.
Electrode placement matters
ECT works by passing a controlled electrical current through the brain under anaesthesia, triggering a brief, generalised seizure. Where the electrodes are placed on the scalp affects both how well the treatment works and what side effects follow. Bilateral placement puts one electrode on each side of the head. Right unilateral (RUL) placement puts both electrodes on the right side only. According to this review, RUL placement is as effective as bilateral placement for major depression, but causes fewer cognitive side effects, such as short-term memory disruption. Memory problems are one of the main reasons people feel wary of ECT, so this finding matters. It suggests that some of the treatment's downsides are not an unavoidable cost of ECT itself, but depend on choices clinicians can make about how it is delivered.
Preventing depression from returning
One question the review highlights, without resolving, is how best to maintain improvement once an initial course of ECT has worked. The options include continuation ECT, in which further sessions are given at wider intervals over time, ongoing antidepressant medication on its own, or a combination of both. The authors describe the evidence on this as mixed. Current studies do not point clearly to one best approach, so in practice this decision is guided largely by clinical judgement rather than settled research.
What seems to be happening in the brain
The review also summarises proposed biological explanations for ECT's effects. Brain imaging studies have found increased gray matter volume, the tissue containing neuron cell bodies, in the hippocampus-amygdala complex after ECT. These are regions involved in memory and emotional processing. Separately, people who show strong connectivity, meaning coordinated activity, between the subgenual anterior cingulate and the middle temporal gyrus before starting treatment tend to respond better to ECT. This raises the possibility that such patterns could eventually help predict who is likely to benefit most. At a chemical level, studies in rodents point to changes in neurotransmitters, including glutamate, GABA, serotonin and dopamine, as part of how ECT works. The authors are careful to note that equivalent evidence in humans remains limited.
Taken together, this review supports ECT as a highly effective treatment for TRD, while being honest that the underlying mechanisms are still only partly understood. That gap between knowing a treatment works and knowing exactly why is common in psychiatry, and it does not diminish the value of the treatment. It simply marks where further research is needed.
If depression has persisted despite trying different medications, it is worth speaking with a GP or psychiatrist about what other options exist, including ECT. Support is available, and it is worth reaching out for it.